Equities research analysts expect bluebird bio, Inc. (NASDAQ:BLUE) to report $19.87 million in sales for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have made estimates for bluebird bio’s earnings. The highest sales estimate is $33.09 million and the lowest is $5.57 million. bluebird bio reported sales of $198.89 million in the […]
